---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-037944"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2021-07-26T23:59:59+00:00"
generated_at: "2026-06-30T02:37:26.408612+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medpace Q2 2021 revenue up 35.8% to $278.3M; net income $39.9M ($1.06 EPS)

## Summary
- Net new business awards of $387.6M (+52.5% YoY) produced a 1.39x book-to-bill ratio.
- Backlog grew 29.8% to $1.7B; revenue backlog conversion rate 17.1%.
- EBITDA $47.9M (17.2% margin), up 36.9% YoY; GAAP net income margin 14.3%.
- Direct costs $203.6M vs $148.4M; SG&A $27.0M vs $21.9M in prior-year quarter.
- On a constant currency basis, organic revenue grew 34.4% and EBITDA grew 41.5%.

## SEC filing metadata
- accession: 0001564590-21-037944
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2021-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000156459021037944/0001564590-21-037944-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000156459021037944/medp-8k_20210726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-037944
- JSON: https://secwatch.observer/filing/0001564590-21-037944.json
- Plain text: https://secwatch.observer/filing/0001564590-21-037944.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.